Journal Articles

* corresponding author
† co-first author’s

2026

  • Carrillo-Gómez JK, Duran-Acevedo CM, Cuastumal-Vásquez CA, Careces-Tarazona JM, Reyes-Zavala A, Llambrich M, Cumeras R, Brezmes J. Volatilomic analysis of urine and breath for prostate cancer detection using complementary GC–MS and electronic nose platforms. Microchemical Journal. 2026 May 9 (IF 5.1, Q1, data from 2024). doi: 10.1016/j.microc.2026.118350. In Press.
  • Giebelhaus RT, Herold M, Harynuk JJ, Alonso DE, Amer B, Broeckling CD, Charisiadis P, Cumeras R, de la Mata AP, Dunn W, Franchina FA, Gika H, Kirwan JA, Muti IH, Najdekr L, Pujos-Guillot E, Stefanuto PH, Steininger-Mairinger T, Thakker A, Fiehn O. Best Practices in GC-MS and GC × GC-MS-Based Metabolomics and Volatile Analyses: An International Survey. Analytical Chemistry. 2026 Apr 24 (IF 6.7, Q1, D1, data from 2024). doi: 10.1021/acs.analchem.5c06918. Epub ahead of print. PMID: 42030522.
  • Roig B, Fernández-Castillejo S, Gumà J, Badia J, Melé M, Salvat M, Querol M, Cumeras R, Rodríguez-Balada M. Metabolomic-driven prediction of the mutational status of healthy individuals with a family history of hereditary breast and ovarian cancer syndrome: the HRRmet study. Scientific Reports. 2026 Jan 31;16(1):6844 (IF 3.9, Q1, data from 2024). doi: 10.1038/s41598-026-35789-8. PMID: 41620477.

2025

  • Llambrich M, van der Kloet FM, Sementé L, Rodrigues A, Samanipour S, Stefanuto PH, Westerhuis JA, Cumeras R*, Brezmes J. GcDUO: an open-source software for GC × GC-MS data analysis. Briefings in Bioinformatics. 2025, 26(2):bbaf080 (IF 7.7, Q1, D1, data from 2024). doi: 10.1093/bib/bbaf080. PMID: 40037642.
  • Fernández-Castillejo S, Badia J, de la Cruz-Merino L, Martín Garcia-Sáncho A, Carnicero-González F, Palazón-Carrión N, Ríos-Herranz E, de la Cruz-Vicente F, Rueda-Domínguez A, Martínez-Banaclocha N, Gómez-Codina J, Labrador J, Martínez-Madueño F, Amigó N, Salar-Silvestre A, Rodríguez-Abreu D, Gálvez-Carvajal L, Sánchez-Beato M, Provencio-Pulla M, Guirado-Risueño M, Nogales E, Sánchez-Margalet V, Jiménez-Cortegana C, Rodríguez-García G, Cumeras R*, Gumà J; Spanish Lymphoma Oncology Group (GOTEL). Ketone Bodies Are Potential Prognostic Biomarkers in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results from the R2-GDP-GOTEL Trial. Cancers. 2025, 17(3):532 (IF 4.4, Q2, data from 2024). doi: 10.3390/cancers17030532. PMID: 39941898.

2024

  • Llambrich M, Ramírez N, Cumeras R*, Brezmes, J. SPME arrow-based extraction for enhanced targeted and untargeted urinary volatilomics. Analytica Chimica Acta. 2024 Nov 15;1329:343261 (IF 5.7, Q1, D1). doi: 10.1016/j.aca.2024.343261. PMID: 39396318.
  • Cruz AK, Alves MA, Andresson T, Bayless AL, Bloodsworth KJ, Bowden JA, Bullock K, Burnet MC, Neto FC, Choy A, Clish CB, Couvillion SP, Cumeras R, Dailey L, Dallmann G, Davis WC, Deik AA, Dickens AM, Djukovic D, Dorrestein PC, Eder JG, Fiehn O, Flores R, Gika H, Hagiwara KA, Pham TH, Harynuk JJ, Aristizabal-Henao JJ, Hoyt DW, Jean-François F, Kråkström M, Kumar A, Kyle JE, Lamichhane S, Li Y, Nam SL, Mandal R, de la Mata AP, Meehan MJ, Meikopoulos T, Metz TO, Mouskeftara T, Munoz N, Gowda GAN, Orešic M, Panitchpakdi M, Pierre-Hugues S, Raftery D, Rushing B, Schock T, Seifried H, Servetas S, Shen T, Sumner S, Carrillo KST, Thibaut D, Trejo JB, Van Meulebroek L, Vanhaecke L, Virgiliou C, Weldon KC, Wishart DS, Zhang L, Zheng J, Da Silva S. Multiplatform metabolomic interlaboratory study of a whole human stool candidate reference material from omnivore and vegan donors. Metabolomics. 2024 Nov 4;20(6):125 (IF 3.5, Q2). doi: 10.1007/s11306-024-02185-0. PMID: 39495321.
  • Llambrich M, Satorra P, Correig E, Gumà J, Brezmes J, Tebé C, Cumeras R*. Easy-Amanida: an R shiny application for the Meta-analysis of aggregate results in clinical metabolomics using Amanida and Webchem. Research Synthesis Methods. 2024 Jul;15(4):687-699 (IF 5.0, Q1, D1). doi: 10.1002/jrsm.1713. PMID: 38480474.
  • Martínez-Banaclocha N, Martínez-Madueño F, Caballé B, Badia J, Blanes M, Aguiar D, Calvo V, Gomez J, Quero C, Espinosa P, Lavernia J, García FR, Guirado M, Llorca C, Cumeras R, Provencio M, Gumà J. A descriptive study of 103 primary cutaneous B-cell lymphomas: clinical and pathological characteristics and treatment from the Spanish Lymphoma Oncology Group (GOTEL). Cancers. 2024 Mar 3; 16(5):1034. (IF 4.5, Q2). doi: 10.3390/cancers16051034. PMID: 38473391.

2023

  • Broeckling C, BegerR, Cheng Ll, Cumeras R, CuthbertsonD, DasariS, DavisW, DunnW, Evans A, Fernandez-Ochoa A, Gika H, Goodacre R, Goodman K, Gouveia G, Hsu P-C, Kirwan J, KodraD, KuligowskiJ, LanR, MongeM, MoussaL, NairS, ReisdorphN, Sherrod S, Ulmer Holland C, Vuckovic D, Yu L-R, Zhang B, Theodoridis G, Mosley J. (2023) Current practices in LC-MS untargeted metabolomics: a scoping review on the use of pooled quality control samples. Analytical Chemistry. 2023 Dec 26; 95(51): 18645-18654 (IF 6.8, Q1, D1). doi: 10.1021/acs.analchem.3c02924. PMID: 38055671.
  • Villalba H, Llambrich M*, Gumà J, Brezmes J, Cumeras R*. A Metabolites Merging Strategy (MMS): Harmonization to Enable Studies’ Intercomparison. Metabolites. 2023 Nov 21; 13(12): 1167 (IF 3.5, Q2). doi: 10.3390/metabo13121167. PMID: 38132849.
  • Cumeras R, Shen T, Valdiviez L, Tippins Z, Haffner BD, Fiehn O*. Differences in the Stool Metabolome between Vegans and Omnivores: Analyzing the NIST Stool Reference Material. Metabolites 2023 Aug 7; 13(8): 921 (IF 3.5, Q2). doi: 10.3390/metabo13080921. PMID: 37623865.

2022

  • Llambrich M, Brezmes J, Cumeras R. The untargeted urine volatilome for biomedical applications: methodology and volatilome database. Biological Procedures Online 2022 Dec 1; 24(1): 20 (IF 6.4, Q1, D1). doi: 10.1186/s12575-022-00184-w. PMID: 36456991.
  • Brezmes J, Llambrich M, Cumeras R*, Gumà J. Urine NMR Metabolomics for Precision Oncology in Colorectal Cancer. International Journal of Molecular Sciences. 2022 Sep 22; 23(19): 11171 (IF 5.6, Q1). doi: 10.3390/ijms231911171. PMID: 36232473.
  • Llambrich M*, Correig E, Gumà J, Brezmes J, Cumeras R*. Amanida: An R package for meta-analysis of metabolomics non-integral data. Bioinformatics. 2022 Jan 3; 38(2): 583-585 (IF 5.8, Q1, D1). doi: 10.1093/bioinformatics/btab591. PMID: 34406360.

2021

  • Mallafré-Muro C†, Llambrich M†, Cumeras, R*, Pardo A, Brezmes J, Marco S, Gumà J. Comprehensive volatilome and metabolome signatures of colorectal cancer in urine: A systematic review and meta-analysis. Cancers. 2021 May 21; 13(11): 2534 (IF 6.575, Q1). doi: 10.3390/cancers13112534. PMID: 34064065.